Weekly assessment of worry: an adaptation of the Penn State Worry Questionnaire for monitoring changes during treatment

Behaviour Research and Therapy
J Stöber, J Bittencourt

Abstract

Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy, 28, 487-495.] for weekly assessment of worry was evaluated in a brief treatment study. Cognitive restructuring techniques were taught to 28 nonclinical high-worriers, 14 of whom served as a control group in a lagged waiting-list design. Results showed that the Penn State Worry Questionnaire-Past Week (PSWQ-PW) was highly reliable and substantially valid in the assessment of both (a) weekly status of worry and (b) treatment-related changes in worry: average Cronbach's alpha was 0.91; average convergent correlation with a past-week adaptation of the Worry Domains Questionnaire [Tallis, F., Eysenck, M. W. and Mathews, A. (1992). A questionnaire for the measurement of nonpathological worry. Personality and Individual Differences, 13, 161-168.] was 0.63 and pre-post improvement on PSWQ-PW showed a 0.71 correlation with the Questionnaire of Changes in Experiencing and Behavior [Zielke, M. and Kopf-Mehnert, C. (1978). Veränderungsfragebogen des Erlebens und Verhaltens. Weinheim, Germany: Beltz Test Gesellschaft.]. It is concluded that the PSWQ-PW is a useful instrument for monitoring pathological worry in experimental and applied settings.

References

Jan 1, 1990·Behaviour Research and Therapy·T J MeyerT D Borkovec
Jan 1, 1983·Behaviour Research and Therapy·T D BorkovecC Lerman
Jan 1, 1995·Behaviour Research and Therapy·V Starcevic
Mar 1, 1996·Behaviour Research and Therapy·J G BeckB J Zebb
Jun 1, 1997·Behaviour Research and Therapy·B F ChorpitaD H Barlow

❮ Previous
Next ❯

Citations

Nov 3, 2004·Journal of Psychosomatic Research·H AndreaC P van Schayck
Sep 7, 2002·Journal of Anxiety Disorders·Joseph I ConstansHeidi Leffler
Aug 28, 2003·Journal of Anxiety Disorders·Melisa RobichaudMichael Conway
May 18, 2004·Sleep Medicine Reviews·Douglas E MoulDaniel J Buysse
Jun 19, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Colleen E CarneyJack D Edinger
Aug 1, 2013·Cognitive and Behavioral Practice·David M FrescoMichael Ritter
May 4, 2016·Psychiatry Research·Beier YaoRicks Warren
Aug 23, 2005·Physiology & Behavior·Roland von KänelJoachim E Fischer
Nov 22, 2012·Behaviour Research and Therapy·Andrea ReineckeJürgen Hoyer
Mar 14, 2009·Journal of Zhejiang University. Science. B·Jie ZhongJun Liu
Dec 28, 2011·Journal of Behavior Therapy and Experimental Psychiatry·Suzanne R Dash, Graham C L Davey
Nov 8, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·K BangemannD Böhm
Apr 7, 2010·Behaviour Research and Therapy·Colleen E CarneyJack D Edinger
Jun 6, 2007·Behavior Modification·Natalie GoldmanNicole J Gervais
Jun 29, 2001·Assessment·M McCarthy-LarzelereG M Manguno-Mire
Jul 20, 2019·Therapeutic Advances in Neurological Disorders·Daniel MerloAnneke van der Walt
May 20, 2010·The Spanish Journal of Psychology·Cristian CastilloJesús Landeira-Fernandez
Dec 12, 2020·The British Journal of Clinical Psychology·Thies LüdtkeStefan Westermann
Aug 1, 2020·Journal of Affective Disorders·Kim HijnePhilip Spinhoven
Jan 9, 2020·BMJ Neurology Open·Susan HoNatasha Bear
Jun 10, 2019·Behaviour Research and Therapy·Eva De JaegereGwendolyn Portzky
May 28, 2019·Journal of Affective Disorders·Luisa WeinerSébastien Weibel
Dec 20, 2017·Journal of Affective Disorders·Nur Hani Zainal, Michelle G Newman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.